ArticleAsian journal of pharmaceutical sciences2026
Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapy.
Xiaojing Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.